Dental Treatment with 30% Trichloroacetic Acid in a Patient with Moderate Hemophilia A
نویسندگان
چکیده
منابع مشابه
Dental Treatment with 30% Trichloroacetic Acid in a Patient with Moderate Hemophilia A
We present the case of a 51-year-old moderate hemophiliac with gingival bleeding due to papillary inflammation and adherence in the molar area 47. After dental diagnosis a calculus was removed and 30% trichloroacetic acid was placed by a pressurized applicator for five seconds; the procedure was repeated until the bleeding stopped, then tranexamic acid was placed by a gauze. The patient chewed ...
متن کاملPost Splenectomy Fatal Pulmonary Embolism in a Patient with Moderate Hemophilia A
Hemophilia A is a bleeding disorder caused by defective production of factor VIII. The main concern associated with the disease is bleeding, especially after trauma and surgeries. Factor VIII replacement therapy is associated with substantial decrease of bleeding events during surgery. However, there have been a number of reports of thromboemblic events in this situ-ation. The present report de...
متن کاملpost splenectomy fatal pulmonary embolism in a patient with moderate hemophilia a
hemophilia a is a bleeding disorder caused by defective production of factor viii. the main concern associated with the disease is bleeding, especially after trauma and surgeries. factor viii replacement therapy is associated with substantial decrease of bleeding events during surgery. however, there have been a number of reports of thromboemblic events in this situ-ation. the present report de...
متن کاملEvaluation of acne scar treatment with a 1450-nm midinfrared laser and 30% trichloroacetic acid peels.
OBJECTIVE To evaluate the efficacy of treatment of established acne scars with a sequential combination of treatment using a 1450-nm, midinfrared, nonablative diode laser with dynamic cooling spray and 30% trichloroacetic acid peels. METHODS In this prospective study 9 patients with atrophic rolling, boxcar, or both types of scars received 4 monthly treatments using a 1450-nm, midinfrared, no...
متن کاملRituximab for Treatment of Hemophilia A with High-Responder Inhibitors
Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Open Journal of Blood Diseases
سال: 2013
ISSN: 2164-3180,2164-3199
DOI: 10.4236/ojbd.2013.31003